VISEON, INC.

Profile

Company Names

VISEON, INC.

Addresses

13700 ALTON PARKWAY, SUITE 167, IRVINE, CA 92618

13900 ALTON PARKWAY, SUITE 125, IRVINE, CA 92618

Phone Numbers

949-662-3959

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$59,575,142.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-05-15 
$2,552,144.00 
$3,000,000.00 
$447,856.00 
 
2
2020-02-10 
$29,449,269.00 
$29,449,269.00 
$0.00 
Equity 
1
2020-01-21 
$27,573,729.00 
$29,449,254.00 
$1,875,525.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RON 
 
BACHE 
DIRECTOR
AQUESYS INC   |  VISEON, INC.
PETER 
 
DAVIS 
EXECUTIVE OFFICER
MENDEL BIOTECHNOLOGY INC   |  GETONE REWARDS LLC   |  GETONE REWARDS INC   |  VISEON, INC.   |  AMPJAR, INC.
PETER 
G 
DAVIS 
EXECUTIVE OFFICER
VISEON, INC.
MICHAEL 
R. 
HENSON 
EXECUTIVE OFFICER, DIRECTOR
REVERSE MEDICAL CORP   |  ONSET MEDICAL CORP   |  ELLIPSE TECHNOLOGIES INC   |  MICARDIA CORP   |  INTERVENTIONAL SPINE INC   |  REBOUND THERAPEUTICS CORP   |  VISEON, INC.   |  B2M MEDICAL, INC.
JILL 
TRACY 
PEARSON 
EXECUTIVE OFFICER
VISEON, INC.
RACHEL 
 
REGINATO 
EXECUTIVE OFFICER
VISEON, INC.
BENJAMIN 
C. 
TSAI 
DIRECTOR
VISEON, INC.
JEFFREY 
J. 
VALKO 
EXECUTIVE OFFICER, DIRECTOR
REVERSE MEDICAL CORP   |  REBOUND THERAPEUTICS CORP   |  VISEON, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-05-15 
2020-02-24
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-10 
2020-02-06
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#